Compare Lustrum:RaQualia Pharma Inc.:4579

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index RaQualia Pharma Inc. 4579 Medicals 東証グロース December 1, 2000 2011.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

RaQualia Pharma Inc. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

RaQualia Pharma Inc. Balance Sheet 2023年12月期 RaQualia Pharma Inc. Balance Sheet 2022年12月期 RaQualia Pharma Inc. Balance Sheet 2021年12月期 RaQualia Pharma Inc. Balance Sheet 2020年12月期 RaQualia Pharma Inc. Balance Sheet 2019年12月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019
Cash and Cash Equivalents
(Percent)
3,715up
(54.1%)down
3,675up
(58.7%)up
2,345up
(44.8%)up
1,394down
(32.8%)down
2,174
(45.0%)
Other Current AssetsHelp
(Percent)
1,242up
(18.1%)down
1,147down
(18.3%)down
1,658up
(31.7%)down
1,440up
(33.9%)up
893
(18.5%)
Tangible Fixed AssetsHelp
(Percent)
574up
(8.3%)up
391up
(6.2%)up
299down
(5.7%)down
333up
(7.8%)up
249
(5.1%)
Intangible Fixed AssetHelp
(Percent)
30up
(0.4%)up
24down
(0.4%)down
34up
(0.6%)down
33up
(0.8%)up
32
(0.7%)
Investments and OthersHelp
(Percent)
1,311up
(19.1%)up
1,020up
(16.3%)down
897down
(17.1%)down
1,051down
(24.7%)down
1,488
(30.8%)
Total AssetsHelp
(Percent)
6,872
(100%)
6,258
(100%)
5,234
(100%)
4,251
(100%)
4,837
(100%)
Total Current LiabilitiesHelp
(Percent)
461down
(6.7%)down
584up
(9.3%)up
429up
(8.2%)up
213down
(5.0%)up
214
(4.4%)
Total Long-term LiabilitiesHelp
(Percent)
291up
(4.2%)up
177up
(2.8%)up
18down
(0.3%)down
27up
(0.6%)up
2
(0.0%)
Shareholder's EquityHelp
(Percent)
6,120up
(89.1%)up
5,497up
(87.8%)down
4,788up
(91.5%)down
4,011down
(94.4%)down
4,621
(95.5%)
Total LiabilitiesHelp
(Percent)
6,872
(100%)
6,258
(100%)
5,234
(100%)
4,251
(100%)
4,837
(100%)

RaQualia Pharma Inc. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

RaQualia Pharma Inc. Profit and Loss Account 2023年12月期 RaQualia Pharma Inc. Profit and Loss Account 2022年12月期 RaQualia Pharma Inc. Profit and Loss Account 2021年12月期 RaQualia Pharma Inc. Profit and Loss Account 2020年12月期 RaQualia Pharma Inc. Profit and Loss Account 2019年12月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019
Amount of Sales
(Percent)
1,901
(100%)
2,918
(100%)
2,776
(100%)
1,107
(100%)
1,703
(100%)
Total Sales
(Percent)
1,901
(100%)
2,918
(100%)
2,776
(100%)
1,107
(100%)
1,703
(100%)
Cost of SalesHelp
(Percent)
245up
(12.9%)up
232down
(7.9%)down
321up
(11.6%)down
138down
(12.5%)down
263
(15.4%)
Other Costs and RevenueHelp 1,980up
(104.1%)up
1,963up
(67.3%)up
1,700up
(61.2%)down
1,576up
(142.4%)up
1,435
(84.3%)
Total CostsHelp 2,225 2,195 2,020 1,714 1,698
Net RevenueHelp 1,656down
(87.1%)down
2,686up
(92.1%)up
2,456up
(88.4%)up
969down
(87.5%)up
1,440
(84.6%)
Earnings Before TaxHelp -294down
(-15.5%)down
851down
(29.2%)down
881up
(31.7%)up
-528down
(-47.7%)down
27
(1.6%)
Net IncomeHelp -324down
(-17.0%)down
723down
(24.8%)down
756up
(27.2%)up
-607down
(-54.8%)down
5
(0.3%)
当期純利益 -324 723 756 -607 5

RaQualia Pharma Inc. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

RaQualia Pharma Inc. Cash Flow Statement 2023年12月期 RaQualia Pharma Inc. Cash Flow Statement 2022年12月期 RaQualia Pharma Inc. Cash Flow Statement 2021年12月期 RaQualia Pharma Inc. Cash Flow Statement 2020年12月期 RaQualia Pharma Inc. Cash Flow Statement 2019年12月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019
Operating Cash Flow(OFC)Help
(Percent)
-719down
(-84.1%)down
1,480up
(97.6%)up
366up
(77.1%)up
-289up
(-79.4%)down
-531
(-58.2%)
Investing Cash Flow(ICF)Help
(Percent)
-135down
(-15.9%)down
-48up
(-3.1%)up
-279down
(-58.8%)down
225up
(61.9%)up
216
(23.7%)
Financing Cash FlowHelp
(Percent)
793up
(92.9%)up
-30down
(-2.0%)up
-16down
(-3.5%)down
-7down
(-1.9%)down
696
(76.3%)
Exchange Difference of Cash and Cash EquivalentsHelp
(Percent)
46up
(5.4%)up
36down
(2.4%)down
109up
(22.9%)up
-68down
(-18.7%)down
-11
(-1.2%)
Net Increase and Decrease in Cash and Cash Equivalentsn -15down
(-1.7%)down
1,439up
(94.9%)up
179up
(37.8%)up
-139down
(-38.1%)down
371
(40.6%)

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

RaQualia Pharma Inc.

Company where related level is highHelp

LTT Bio-Pharma Co.,Ltd.
Kidswell Bio Corporation
Chiome Bioscience Inc.
Eisai Co.,Ltd.
FunPep Company Limited
Astellas Pharma Inc.
TOWA PHARMACEUTICAL CO.,LTD.
ASKA Pharmaceutical Co.,Ltd.
Mitsubishi Tanabe Pharma Corporation
KYORIN Pharmaceutical Co., Ltd.